Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07420205 · ClinicalTrials.gov registry record · Phase 2
Sleep Health in U.S. Marines
A Phase 2 study, sponsored by San Diego State University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 860
- Enrollment target
NCT07420205: Recruiting Phase 2 study, sponsored by San Diego State University.
NCT07420205 is a Phase 2 study that is actively recruiting participants, run by San Diego State University. The registered enrollment target is 860 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (547% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07420205, a Phase 2 study, is actively recruiting participants, sponsored by San Diego State University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 860 participants
- Enrollment target
Study Summary
The goal of this study is to test a sleep health program designed specifically for U.S. Marine Corps personnel. Researchers want to determine if this program helps Marines improve the participants sleep quality and overall mental health. The study will evaluate whether the program improves sleep quality and duration and reduces symptoms of depression, anxiety, PTSD, and suicide ideation. There are three distinct sleep health programs that will be evaluated; participants will be randomly assigned to one of five groups to receive different combinations of the sleep health programs. To measure results, researchers will use participant surveys for all enrolled participants and wearable sleep-tracking devices for a sub-set of participants. The study team expects that Marines who receive the most comprehensive version of the program will show the greatest improvements in sleep and psychological well-being.
Primary Outcome
The Patient Health Questionnaire-9 will provide a measure of depressive symptoms. Item scores will be summed to estimate severity of symptoms (range: 0-27).
Interventions
- BEHAVIORAL Sleep Leadership
- BEHAVIORAL Circadian, Light, and Sleep Skills in Shipboard Military (CLASS-MC) Personnel Program
- BEHAVIORAL Insomnia Coach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 860 participants |
| Start Date | 2026-03-31 |
| Est. Completion | 2027-06 |
| Phase | Phase 2 |
What NCT07420205 shows while recruiting
NCT07420205 is an interventional study that assigns participants to a tested intervention. The registered 860 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (547% higher).
The record links to 0 conditions, and to 3 interventions - of which Sleep Leadership is the first listed.
NCT07420205 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07420205 about?
NCT07420205 is a clinical study titled "Sleep Health in U.S. Marines". The goal of this study is to test a sleep health program designed specifically for U.S. Marine Corps personnel. Researchers want to determine if this program helps Marines improve the participants sleep quality and overall mental health. The study will evaluate whether the program improves sleep qua...
What is the current status of trial NCT07420205?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 860 participants. The study started on 2026-03-31. Estimated completion is 2027-06.
What interventions are being tested in trial NCT07420205?
The interventions under investigation include: Sleep Leadership (BEHAVIORAL), Circadian, Light, and Sleep Skills in Shipboard Military (CLASS-MC) Personnel Program (BEHAVIORAL), Insomnia Coach (BEHAVIORAL).
Who is sponsoring clinical trial NCT07420205?
This trial is sponsored by San Diego State University, which has 118 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07420205's enrollment target sits among peer trials
860 33rd of 2000 higher than 1,966 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04541381 · 860 participants · NA
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care
- NCT05211895 · 860 participants · Phase 3
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC
- NCT06161025 · 860 participants · Phase 2
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- NCT06541574 · 860 participants · Phase 2
Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI